MIDLAND, Mich - October 18, 2017 - With decades of technical and industry expertise, Dow Pharma Solutions – a business unit of the DowDuPont Specialty Products Division – addresses the toughest challenges its customers face in pharmaceutical applications, drug delivery systems and productivity enhancement. At CPhI Worldwide, Oct. 24-26, the business will share the latest excipient solutions at booth #102A50.
Dow’s portfolio of trusted solutions for the pharmaceutical markets now includes products based on the heritage Dow Corning silicone technology platform, to enable optimal drug delivery systems across oral, transdermal and topical dosage forms. At the show, Dow will display customer samples and discuss the following technologies:
Dow Corning® topical excipients specifically developed to facilitate patient compliance, help improve aesthetic and increase formulation flexibility.
Dow Corning® innovative range of topical ingredients with enhanced spreading and sensory properties enabling novel approaches to acne management such as patches.
Productivity and solubility enhancement polymers:
METHOCEL™ DC2 for direct compression which helps shorten development time and reduces manufacturing costs by up to 60 percent.
ETHOCEL™ High Productivity (HP) Polymers optimized for dry powder layering processes and can coat 40-60 percent faster than current multi-particulate coating technologies.
AFFINISOL™ HPMCAS uniquely tailored to address the solubilization performance requirements of active pharmaceutical ingredients through stable solid dispersion and inhibition of API crystallization. AFFINISOL™ HPMC HME provides improved thermal properties conceived for hot melt extrusion.
The innovative properties of AFFINISOL HPMCAS High Productivity grade to facilitate higher solids content for increased throughput while maintaining optimal solubility, earned the technology a nomination for CPhI’s Pharma Awards 2017. Winners to be announced Oct. 24 during an awards ceremony on-site.